Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Matthew Morton

Matthew Morton

Senior Manager, Corporate Audience Marketing

Connect with Matthew Morton on LinkedIn

About the author: As Senior Marketing Manager for Elsevier Corporate Audiences and Professional Services, I bring a my passion for digital storytelling, communications, advancing technologies, and customer insights to drive our go-to-market and planning strategy. All topics I cover and discuss here relate to emerging technologies (across industries), data science, open innovation, and communication strategy. Please feel free to reach out to further the discussion.

Posts by Matthew Morton

AI Disease Modeling Supports Precision Medicine for Cancer

Posted on June 1st, 2021 in Pharma R&D

Precision medicine has offered a lot of hope for the treatment of cancer, as it makes it possible to tackle the multi-faceted disease with a more personalized, patient-specific approach. Meanwhile, researchers are also becoming increasingly interested in applications for artificial intelligence in the development of drugs and therapies. Could AI and precision medicine work together in the fight against cancer?


Complimentary trend analysis report: Emerging trends in pancreatic cancer research

Posted on September 17th, 2020 in Pharma R&D

Pancreatic cancer sadly remains one of the most deadly cancers in existence, partly because it often goes undiagnosed until it has already metastasized. Finding new and better therapies to fight pancreatic cancer means accelerating the research. A new report just released from Elsevier’s Professional Services Group, titled Text mining to identify emerging trends in the pancreatic cancer literature, shows how that is possible.


Infographic: Elsevier’s Professional Services team provides COVID-19 insights

Posted on May 1st, 2020 in COVID-19

Check out a special infographic we created to show how Elsevier’s Professional Services team can support your COVID-19 research.